The IHC staining results revealed that activated Notch1 signaling was very robust in sh-Luc treated tumor tissue as compared to sh-ASPH treated cells (Fig 5D), suggesting that targeting ASPH with shRNAs substantially inhibits Notch signaling and blunts CCA growth. The gene discussed is NOTCH1; the disease is neoplasm.